Article
GSK to stop selling blood cancer drug Blenrep in United States
Rating:
0.0
Views:
41
Likes:
1
Library:
1
GSK will stop selling its blood cancer drug Blenrep in the United States, it said on Tuesday, in another setback for the British drugmaker's oncology business.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value